Skip to search formSkip to main contentSkip to account menu

Stromal Neoplasm

Known as: stromal tumours, Stromal Cell Tumor, tumors stromal 
A benign or malignant mesenchymal neoplasm composed of stromal cells. Representative examples include gastrointestinal stromal tumor, endometrial… 
National Institutes of Health

Related topics

Related topics

9 relations
Connective Tissue CellsConnective and Soft TissueNeoplastic CellNeoplastic Stromal Cell

Narrower (1)

Stromal sarcoma

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1
Acquired resistance to EGF receptor (EGFR) tyrosine kinase inhibitors (TKIs) is inevitable in metastatic EGFR-mutant lung cancers… 
Review
2010
Review
2010
Relationship between exposure to sunitinib and efficacy and tolerability endpoints in patients with cancer: results of a pharmacokinetic/pharmacodynamic meta-analysis
PurposeIn this pharmacokinetic/pharmacodynamic meta-analysis, we investigated relationships between clinical endpoints and… 
Highly Cited
2008
Highly Cited
2008
Dose‐dependent, complete response to imatinib of a metastatic mucosal melanoma with a K642E KIT mutation
Dear Sir, We recently reported mutations and copy number increases of KIT in 40% or mucosal and acral melanomas, as well as 30… 
Review
2007
Review
2007
Management of ovarian stromal cell tumors.
PURPOSE To describe the clinical management of ovarian stromal cell tumors, which are a heterogeneous group of neoplasms that… 
Highly Cited
2007
Highly Cited
2007
Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib.
Sunitinib is an inhibitor of the vascular endothelial growth factor and platelet-derived growth factor receptors, and it has… 
Highly Cited
2005
Highly Cited
2005
Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice.
Imatinib mesylate is a potent and specific tyrosine kinase inhibitor against c-ABL, BCR-ABL, and c-KIT, and has been demonstrated… 
Review
2004
Review
2004
Hedgehog signaling promotes prostate xenograft tumor growth.
During fetal prostate development, Sonic hedgehog (Shh) expression by the urogenital sinus epithelium activates Gli-1 expression… 
Highly Cited
2004
Highly Cited
2004
Kinase Inhibition with BAY 43–9006 in Renal Cell Carcinoma
BAY 43–9006 is an oral inhibitor of CRAF, wild-type BRAF, mutant V599E BRAF, vascular endothelial growth factor receptor (VEGFR… 
Highly Cited
2003
Highly Cited
2003
Classification and subtype prediction of adult soft tissue sarcoma by functional genomics.
Highly Cited
2003
Highly Cited
2003
Structure of a c-Kit Product Complex Reveals the Basis for Kinase Transactivation*
The c-Kit proto-oncogene is a receptor protein-tyrosine kinase associated with several highly malignant human cancers. Upon… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)